InMed

InMed AI Studio

Empowering healthcare through AI Innovation and Inclusion

Who We Are

We are scientists, we are technologists. We are humans who care.
 
At In-Med AI, we strive to capture the untapped potential of AI in healthcare leveraging multi-modal data across the globe. Our solutions are tailored to each individual with a commitment to inclusion and innovation.
 
We are empowering the healthcare ecosystem, saving radiologists’ time and producing better results for clinicians and practitioners through AI innovation.
 
Grounded in our values of curiosity and inclusivity, we want everyone to benefit from the work we do.
 
                                We are In-Med AI.

Our Journey

2018

India entity
formed

BIRAC GOI
grant

2020

NASSCOM AI Innovator Award

GE Healthcare India Edison Accelerator

Neuroshield™ MVP launched

2021

ET Business
Award

NASSCOM Emerge 50 Tech Startup

US entity
formed

First Global IP secured

2022

$3.13 M
seed round

Neuroshield™ full version launched

2023

First US FDA 510 K Clearance Received

2024 (Feb to March)

Oncoshield launch

InMed AI
Studio launch

Orthoshield product launch

Neuroshield CT product launch

2024 (Forthcoming in April)

Vivoshield launch

Empowering Through Innovation and Impact​

The InMed Difference

As a globally distributed health-tech AI company, we are leading the way in precision and preventive medicine!

Precision and Personalized Medicine

We are the first in the world to develop ethnicity-based reference ranges and composite reference ranges that do not oversample Caucasian data.

In addition to the global standards of age and gender, we include ethnicity and micro-ethnicity in our models to enhance the relevance of our outputs to individual patients thus enabling the clinician to provide personalized care.

Enhanced data quality reduces variability and increases consistency and enables the practice of precision and personalised medicine.

Enhanced data quality increases accuracy and consistency of surrogate endpoints, through integrative biomarker development.

Preventive Healthcare

Our patented technology is used to build predictive prognostic models based on multimodal and multivariate pattern analysis of image, text, and signal inputs using AI technology.

Use of curated, ethnicity-specific reports enhance speed, accuracy and the availability of diagnostic insights for early detection and treatment.

Flexible & Customizable Integration and Deployment

We offer various forms of integration and customization for standardized and non-standardized work-flow environments.

Our tools can be seamlessly integrated with PACS / RIS systems, modality consoles, and reports delivered in different formats and options such as phone, emails, and via PACS and EHR.

All our products can be deployed both on the cloud and on the cloud.

Careers

We look forward to partnering with individuals and teams who are committed to shaping a future where healthcare is more accessible, equitable and patient-centric than ever before

 

 

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept